Hong Kong stocks are moving differently | Most of the innovative pharmaceutical concepts are rising, industry BD transactions continue to be in high spirits, and the logic of policy support and commercial profit realization remains unchanged.

According to the Securities Times app, most of the innovative drug concepts are on the rise. Colenbo Pharmaceutical (06990.HK) rose 8.62% to 428.4 Hong Kong dollars; Rongchang Biology (09995.HK) rose 8.11% to 75.3 Hong Kong dollars; Nuocheng Jianhua (09969.HK) rose 6.67% to 11.04 Hong Kong dollars; Kangnouya-B (02162) rose 6.21% to 59 Hong Kong dollars; Hengrui Pharmaceutical (01276) rose 5.23% to 55.3 Hong Kong dollars.